Overview

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets under fasted conditions
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Etiracetam
Levetiracetam
Piracetam